Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment

Stahl, Andreas; Nakanishi, Hidehiko; Lepore, Domenico; Wu, Wei-Chi; Azuma, Noriyuki; Jacas, Carlos

Visualitza

Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment, 2025 (118.9Kb)

Autor/a

Data

2025-08

Enllaç permanent

http://hdl.handle.net/11351/13880

DOI

10.1177/25158414251321730

ISSN

2515-8414

WOS

001484255500001

PMID

40342575

Registre Complet

Paraules clau

Lactants; Aflibercept intravitreal; Retinopatia del prematur

Citació recomanada

Stahl A, Nakanishi H, Lepore D, Wu WC, Azuma N, Jacas C, et al. Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment. Ther Adv Ophthalmol. 2025 Aug;17:25158414251321730.